Papayannidis C, Petracci E, Zappasodi P, Fracchiolla N, et al. INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia. Cancer 2025;131:e35820.
PMID: 40120068